A pair of San Antonio biotech companies, BioBridge Global and StemBioSys Inc., have agreed to expand the scope of their collaborative relationship in an effort to bring a new source of stem cells to the research market.
Recent Posts
- What will be born of the marriage of de-extinction firm Colossal and animal cloning biotech Viagen?
- Behind the FDA’s Elimination of REMS Program for CAR T-Cell Therapies
- Scientists discover how hair cells can help heal skin faster
- Engineered Bone Marrow Model Advances CRISPR-CAR T Research in AML
- Stem Cells Prevent Heart Failure After Heart Attack
- We need to start thinking of AI as “normal”

